Issue 5, 2019

Dual inhibitors of LSD1 and spermine oxidase

Abstract

We have previously described the synthesis and evaluation of 3,5-diamino-1,2,4-triazole analogues as inhibitors of the flavin-dependent histone demethylase LSD1. These compounds are potent inhibitors of LSD1 without activity against monoamine oxidases A and B, and promote the elevation of H3K4me2 levels in tumor cells in vitro. We now report that the cytotoxicity of these analogues in pancreatic tumor cells correlates with the overexpression of LSD1 in each tumor type. In addition, we show that a subset of these 3,5-diamino-1,2,4-triazole analogues inhibit a related flavin-dependent oxidase, the polyamine catabolic enzyme spermine oxidase (SMOX) in vitro.

Graphical abstract: Dual inhibitors of LSD1 and spermine oxidase

Supplementary files

Article information

Article type
Research Article
Submitted
12 Dec 2018
Accepted
06 Feb 2019
First published
08 Feb 2019

Med. Chem. Commun., 2019,10, 778-790

Dual inhibitors of LSD1 and spermine oxidase

S. Holshouser, M. Dunworth, T. Murray-Stewart, Y. K. Peterson, P. Burger, J. Kirkpatrick, H. Chen, R. A. Casero and P. M. Woster, Med. Chem. Commun., 2019, 10, 778 DOI: 10.1039/C8MD00610E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements